MAPT and Alzheimer disease: The above model of neurodegeneration is acute and amyloid-induced, whereas AD is chronic and appears to require tau pathology, which can be driven by pathways independent of Aβ (van der Kant et al., 2020), so we next tested whether P2ry6 knockout is beneficial in a chronic model of tauopathy.